GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Weleader Biomedical Co Ltd (ROCO:7713) » Definitions » Research & Development

Weleader Biomedical Co (ROCO:7713) Research & Development : NT$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Weleader Biomedical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Weleader Biomedical Co's Research & Development for the three months ended in Mar. 2025 was NT$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0 Mil.


Weleader Biomedical Co Research & Development Historical Data

The historical data trend for Weleader Biomedical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weleader Biomedical Co Research & Development Chart

Weleader Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
3.99 - - - -

Weleader Biomedical Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Weleader Biomedical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Weleader Biomedical Co  (ROCO:7713) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Weleader Biomedical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Weleader Biomedical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Weleader Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 80, Minzu 1st Road, Floor 19, Sanmin District, Kaohsiung, TWN
Weleader Biomedical Co Ltd is mainly engages in the sales of medical testing reagents and medical devices; and the leasing of testing instruments.

Weleader Biomedical Co Headlines

No Headlines